Vicore announces changes in management team
Gothenburg, November 3, 2020 – Vicore Pharma Holding AB (publ), a pharmaceutical company dedicated to developing innovative medicines for rare lung disorders, today announces changes to the management team.
The management team in Vicore will now consist of the following persons:
- Carl-Johan Dalsgaard, CEO
- Hans Jeppsson, CFO
- Rohit Batta, CMO
- Johan Raud, CSO
- Elin Rosendahl, VP Clinical Development (assumes on November 16)
- Ola Camber, Head of Pharmaceutical R&D
- Nina Carlén, Chief Adminstrative Officer
- Johanna Gräns, Preclinical Development
”As the development of Vicore’s program progresses, we continuously review the composition of the management team. It is key that we efficiently run our projects in order to achieve the company’s goals and as part of that we are now making changes to the management team. ”says Carl-Johan Dalsgaard, CEO.
For further information, please contact:
Carl-Johan Dalsgaard, CEO, tel: +46 70 975 98 63, firstname.lastname@example.org
This information was submitted for publication on November 3, 2020, at 13:00 CET
Source: Vicore Pharma